Tahir Turk | Health Professions | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Tahir Turk
Dow University of Health Sciences, Australia

Tahir Turk
Affiliation Dow University of Health Sciences
Country Australia
Scopus ID 37091848000
Documents 20
Citations 278
h-index 9
Subject Area Health Professions
Event International Invention Awards
ORCID 0000-0002-8119-4171

Tahir Turk is a researcher associated with Dow University of Health Sciences whose scholarly activities focus on public health, health promotion, nutrition-sensitive social protection, social and behaviour change communication (SBCC), and water, sanitation and hygiene initiatives. His publication record demonstrates engagement with evidence-based interventions designed to improve health outcomes in diverse communities and low- and middle-income country settings. Through interdisciplinary collaborations, his work contributes to the understanding of behavioural determinants of health and the development of context-specific communication strategies.[1]

Abstract

This article reviews the academic profile of Tahir Turk and highlights contributions to public health research, nutrition-sensitive interventions, behavioural communication strategies, and WASH-related initiatives. His publications demonstrate a commitment to co-design methodologies, systematic evidence synthesis, and community-centered health promotion. The body of work reflects practical applications of behavioural science within public health programs and supports the advancement of effective communication frameworks for improving population health outcomes.[2]

Keywords

Public Health, Health Promotion, Social and Behaviour Change Communication, Nutrition, WASH, Community Engagement, Co-design Research, Systematic Review.

Introduction

Modern public health challenges increasingly require integrated approaches that combine behavioural science, community participation, and evidence-informed interventions. Tahir Turk’s research addresses these priorities through studies examining nutrition-sensitive social protection programs, obesity prevention strategies, and sanitation-related behavioural change initiatives. His work contributes to contemporary discussions regarding the implementation and evaluation of public health communication programs.[3]

Research Profile

According to available scholarly metrics, Tahir Turk has authored twenty indexed publications, accumulating 278 citations and an h-index of 9. His primary subject classification falls within Health Professions, with interdisciplinary engagement across public health, nutrition, health communication, and implementation research. The research portfolio demonstrates sustained attention to improving health outcomes through participatory and culturally informed intervention models.[1]

Research Contributions

  • Development of co-designed WASH communication strategies in Kiribati.
  • Systematic review of social and behaviour change communication interventions within nutrition-sensitive social protection programs.
  • Integration of co-design methodologies into formative research frameworks for low- and middle-income countries.
  • Research supporting obesity prevention communication strategies in Pacific Island contexts.

Publications

  • Co-designing water sanitation and hygiene (WASH) messages for a social and behaviour change campaign in Kiribati (2026).
  • Effect of Integrating Social and Behavior Change Communication Strategies in Nutrition-Sensitive Social-Protection Programs on Specific Nutritional Outcomes: A Systematic Review (2026).
  • Integrating co-design into formative research for a SBCC entry-point platform for nutrition-sensitive social protection programs (2025).
  • Conducting formative research during a pandemic threat to inform obesity prevention communication strategies in Tonga (2024).

Research Impact

The impact of Turk’s scholarship is reflected in its emphasis on practical implementation and community engagement. His studies support policymakers, public health practitioners, and development organizations seeking evidence-based approaches to behavioural change and nutrition improvement. The combination of systematic reviews, formative research, and co-design methods strengthens the applicability of findings across diverse health settings.[4]

Award Suitability

Tahir Turk’s contributions align with the objectives of the International Invention Awards by demonstrating innovation in health communication, participatory research design, and public health intervention development. The integration of behavioural science principles into real-world health programs illustrates scholarly originality and practical relevance. His research record provides evidence of sustained academic productivity and measurable scholarly influence within the field of health professions.[5]

Conclusion

The academic profile of Tahir Turk highlights a focused commitment to advancing public health through behavioural communication research, nutrition-sensitive programming, and participatory intervention design. His body of work contributes valuable insights for researchers and practitioners working to improve health outcomes through evidence-based and community-centered approaches.

References

  1. Elsevier. (n.d.). Scopus author details: Tahir Turk, Author ID 37091848000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37091848000
  2. Public Health in Practice. (2026). Co-designing water sanitation and hygiene (WASH) messages for a social and behaviour change campaign in Kiribati.
    DOI: https://doi.org/10.1016/j.puhip.2026.100821
  3. Nutrition Reviews. (2026). Effect of Integrating Social and Behavior Change Communication Strategies in Nutrition-Sensitive Social-Protection Programs on Specific Nutritional Outcomes.
    DOI: https://doi.org/10.1093/nutrit/nuaf063
  4. PLOS One. (2025). Integrating co-design into formative research for a SBCC entry-point platform.
    DOI: https://doi.org/10.1371/journal.pone.0310288
  5. Health Promotion Journal of Australia. (2024). Conducting formative research during a pandemic threat to inform the development of an obesity prevention strategy in Tonga.
    DOI: https://doi.org/10.1002/hpja.821
  6. medRxiv Preprint. (2024). Integrating co-design into formative research for nutrition-sensitive social protection programs.
    DOI: https://doi.org/10.1101/2024.09.08.24313037

Leticia Szadai | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Leticia Szadai
Lund University, Sweden

Leticia Szadai
Affiliation Lund University
Country Sweden
Google Scholar ID CNcrXOIAAAAJ
Documents 27
Citations 175
h-index 7
Subject Area Medicine and Dentistry
Event International Invention Awards

The Best Researcher Award recognizes researchers whose scholarly activities have contributed to the advancement of knowledge and innovation within their respective disciplines. Leticia Szadai of Lund University has developed a research profile centered on melanoma biology, proteomics, biomarker discovery, and translational cancer research. Her work integrates advanced molecular analysis with clinical applications, supporting improved understanding of melanoma progression, recurrence mechanisms, and therapeutic opportunities. Through collaborative research efforts, she has contributed to the generation of valuable datasets and analytical frameworks relevant to modern oncology research.[1]

Abstract

This article summarizes the academic achievements and research contributions of Leticia Szadai. Her work primarily focuses on melanoma proteomics, molecular pathology, biomarker identification, and translational oncology. Through participation in multidisciplinary investigations, she has contributed to the development of proteomic resources and analytical methods that support precision medicine approaches in cancer research.[2]

Keywords

Melanoma, Proteomics, Molecular Pathology, Biomarkers, Translational Medicine, Cancer Research, Precision Oncology, Tumor Biology.

Introduction

Advances in cancer research increasingly depend on interdisciplinary methodologies that connect molecular science with clinical practice. Leticia Szadai has contributed to this field through studies examining melanoma biology and the molecular factors associated with disease progression and recurrence. Her research reflects contemporary efforts to improve diagnostic and prognostic strategies through large-scale proteomic investigation.[3]

Research Profile

As a researcher affiliated with Lund University, Leticia Szadai has participated in projects involving molecular oncology, clinical proteomics, and translational medicine. Her publication record demonstrates engagement with collaborative international research initiatives focused on melanoma tissue analysis, mitochondrial regulation, immune response mechanisms, and biomarker discovery. These efforts contribute to the broader objective of enhancing evidence-based cancer management.[4]

Research Contributions

  • Contributed to studies establishing comprehensive melanoma proteome atlases.
  • Investigated molecular pathology and protein expression patterns in melanoma.
  • Explored mitochondrial dysfunction and immune response dysregulation associated with melanoma recurrence.
  • Participated in biomarker discovery using archived tumor samples and advanced proteomic technologies.
  • Supported research into kinase signaling pathways and translational applications in oncology.

Publications

  • The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome (2021).
  • The Human Melanoma Proteome Atlas—Defining the Molecular Pathology (2021).
  • Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence (2023).
  • Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out (2021).
  • A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma (2021).

Research Impact

The available citation metrics indicate that Leticia Szadai’s research outputs have attracted scholarly attention within oncology and translational medicine communities. Her involvement in high-impact collaborative studies has supported the development of proteomic resources that facilitate future investigations into melanoma progression, biomarker validation, and personalized therapeutic strategies. These contributions demonstrate measurable academic influence and continuing relevance to cancer research.[5]

Award Suitability

Leticia Szadai’s research portfolio aligns with the objectives of the International Invention Awards and the Best Researcher Award category. Her scholarly contributions reflect innovation in proteomic methodology, translational cancer research, and biomarker development. The combination of publication activity, collaborative leadership, and clinically relevant outcomes supports recognition for contributions to medicine and dentistry-related scientific advancement.[6]

Conclusion

Leticia Szadai has established a research profile characterized by rigorous investigation of melanoma biology and proteomics. Her contributions to translational oncology, biomarker discovery, and molecular pathology have supported scientific understanding of cancer mechanisms and potential clinical applications. These achievements provide a strong foundation for academic recognition through the Best Researcher Award.

References

  1. Elsevier. (n.d.). Google Scholar author details: Leticia Szadai
    https://scholar.google.com/citations?hl=hu&user=CNcrXOIAAAAJ
  2. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.451
  3. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Defining the Molecular Pathology. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.473
  4. Szadai L et al. (2023). Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.1495
  5. Szadai L et al. (2021). Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out. Cancers.
    https://doi.org/10.3390/cancers13236105
  6. Velasquez E et al. (2021). A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.466

A. Marcell Szasz | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards

Excellence in Research Award

A. Marcell Szasz
Semmelweis University, Hungary

A. Marcell Szasz
Affiliation Semmelweis University
Country Hungary
Scopus ID 24723204500
Documents 147
Citations 4,107
h-index 29
Subject Area Medicine and Dentistry
Event International Invention Awards
Google Scholar ID eeJzLNQAAAAJ

The Excellence in Research Award recognizes researchers whose scholarly activities demonstrate sustained contributions to scientific advancement, interdisciplinary collaboration, and measurable research impact. A. Marcell Szasz of Semmelweis University has developed a notable academic profile in medicine and cancer research through influential publications, biomarker studies, translational oncology investigations, and evidence-based clinical analyses.[1] His publication record and citation performance indicate significant engagement within the international scientific community.[2]

Abstract

A. Marcell Szasz has contributed to the fields of oncology, molecular medicine, prognostic biomarker analysis, and cancer outcome prediction. His research portfolio encompasses gene-expression studies, clinical meta-analyses, cancer progression modeling, and translational medical investigations. Through collaborations with international research teams, his work has informed understanding of disease mechanisms and patient stratification approaches in modern oncology.[2]

Keywords

Oncology, Biomarkers, Precision Medicine, Cancer Research, Meta-analysis, Gene Expression, Translational Medicine, Clinical Research.

Introduction

Research excellence is frequently evaluated through scientific influence, publication quality, citation impact, and contribution to knowledge development. Within this context, A. Marcell Szasz has established a scholarly presence through studies addressing cancer biology, prognostic biomarkers, and therapeutic outcomes. His work contributes to evidence-based approaches used in clinical and translational medicine.[3]

Research Profile

The researcher maintains a substantial publication portfolio consisting of 147 indexed documents, more than 4,100 citations, and an h-index of 29. His academic activity is primarily associated with medicine, oncology, pathology, molecular diagnostics, and clinical outcome assessment. These metrics reflect both productivity and sustained visibility within international scientific literature.[1]

Research Contributions

  • Investigation of microRNA regulation and metastatic progression in breast cancer.
  • Development and validation of transcriptomic biomarkers associated with survival outcomes.
  • Comprehensive meta-analyses supporting clinical decision-making in oncology.
  • Studies examining genomic alterations and evolutionary pathways of metastatic disease.

Publications

Among his most cited publications are studies on miR-31 and breast cancer metastasis, transcriptomic biomarker validation in gastric cancer, urachal carcinoma meta-analysis, tamoxifen-response biomarkers, and phylogenetic analyses of metastatic progression.[4] These works have received substantial scholarly attention and have been referenced extensively in subsequent research.

Research Impact

The citation performance associated with A. Marcell Szasz demonstrates broad engagement from researchers across oncology, pathology, molecular biology, and clinical medicine. His publications have contributed to methodological refinement, biomarker validation, and evidence synthesis efforts that support future investigations and clinical translation.[5]

Award Suitability

The Excellence in Research Award emphasizes scientific rigor, research influence, and sustained scholarly contribution. Based on publication metrics, citation impact, interdisciplinary collaborations, and documented contributions to cancer research, A. Marcell Szasz demonstrates characteristics commonly associated with distinguished academic achievement and research leadership.[6]

Conclusion

A. Marcell Szasz has contributed meaningfully to contemporary oncology research through studies addressing biomarkers, disease progression, and clinical outcomes. His publication record, citation profile, and participation in influential collaborative projects provide a strong foundation for recognition within an academic award framework focused on research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: A. Marcell Szasz, Author ID 24723204500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24723204500
  2. Valastyan S., Reinhardt F., et al. (2009). miR-31 inhibits breast cancer metastasis. Cell.
    DOI: https://doi.org/10.1016/j.cell.2009.03.047
  3. Szász A.M., Lánczky A., et al. (2016). Cross-validation of survival associated biomarkers in gastric cancer. Oncotarget.
    DOI: https://doi.org/10.18632/oncotarget.10337
  4. Brown D., Smeets D., Székely B., Szasz A.M., et al. (2017). Phylogenetic analysis of metastatic progression in breast cancer. Nature Communications.
    DOI: https://doi.org/10.1038/ncomms14944
  5. Mihály Z., Kormos M., Lánczky A., et al. (2013). Gene expression-based biomarkers predicting outcome after tamoxifen treatment.
    DOI: https://doi.org/10.1007/s10549-013-2619-y
  6. Szarvas T., Módos O., Niedworok C., et al. (2016). Clinical, prognostic, and therapeutic aspects of urachal carcinoma.
    DOI: https://doi.org/10.1016/j.urolonc.2016.04.012

Irineu Loturco | Health Professions | Best Researcher Award

Published on by Invention Awards

Prof Dr. Irineu Loturco | Health Professions | Best Researcher Award

Prof. Dr. Irineu Loturco | Federal University of Sao Paulo | Brazil 

Prof. Dr. Irineu Loturco Filho (born May 22, 1972, Brazil) is a distinguished researcher, educator, and practitioner in sports science, specializing in high-performance training, neuromuscular adaptations, strength, power, and speed development. He holds a degree in Sports from the University of São Paulo (1999), a Professional Master’s in High-Performance Sports from Universidad Autónoma de Madrid (2009), and both a Master’s (2010) and PhD (2014) in High-Performance Sports from Universidad Pablo de Olavide, Spain, where his research focused on the effects of training load sequencing on strength, speed, and muscle power. Loturco currently serves as Director of Sport Science & Research Leader at the Núcleo de Alto Rendimento Esportivo de São Paulo (NAR-SP), coordinating postgraduate programs in training methodology and supervising research on training periodization, performance monitoring, and neuromuscular development. He is also a professor and advisor at the Federal University of São Paulo (UNIFESP) and a visiting professor at the University of South Wales, contributing to both national and international sports science research. Over his career, he has worked with elite athletes and professional teams including Clube Atlético Mineiro, Sociedade Esportiva Palmeiras, and Sport Club Corinthians Paulista, as well as national organizations such as the Brazilian Football Confederation and Brazilian Karate Confederation. His current research investigates strategies to enhance athletic performance, including weighted vest training, seasonal performance variation, and injury prevention. Recognized internationally for his contributions, Loturco has received awards such as the 2019 SCS Investigator Award and honors for his work in adaptive sports and high-performance athlete development, solidifying his position as a leading authority in strength and conditioning science.

Profile: Orcid

Featured Publications

Survey Studies: Connecting Sport Science to Coaching Practice – International Journal of Sports Physiology and Performance

Training at Different Velocity Zones: Does It Really Matter? – International Journal of Sports Physiology and Performance

Neuromuscular and Performance Responses to Resisted Sprint Loads in Elite Female Sprinters

Effects of a Short-Term Ballistic Training Program on Performance and Strength Deficit in Elite Youth Female Soccer Players – Sports,

Effects of Loaded and Unloaded Jumps Used as Priming Activities in Elite Male Rugby Union Players

Andrzej Bieniek | Dermatologic Surgery | Excellence in Innovation Award

Published on by Invention Awards

Assist Prof. Dr. Andrzej Bieniek | Dermatologic Surgery | Excellence in Innovation Award

Assist Prof. Dr. Andrzej Bieniek | Private Center for Plastic Surgery | Poland

Assist Prof. Dr. Andrzej Bieniek, MD, PhD, is a highly respected Associate Professor at the Medical University of Wrocław, Poland . He is a specialist in both plastic and general surgery, known for blending clinical expertise with innovative research. As Chair of the Center of Dermatology and Surgery, he has built a reputation for delivering exceptional patient care while advancing surgical techniques that improve safety and outcomes. His clinical leadership and commitment to academic development have made him a mentor to many in the medical field. By combining his surgical precision with a passion for education and research, Dr. Bieniek continues to influence the growth of dermatologic and reconstructive surgery, both locally and internationally , shaping the future of modern surgical practice.

Profile

Scopus

Education

Dr. Bieniek began his medical journey at the Faculty of Medicine in Wrocław , where he laid the foundation for his future career in surgery. After completing his initial medical training, he pursued a specialization in general surgery before advancing into the field of plastic surgery. His passion for innovation drove him to conduct research in advanced biomaterials, leading to a PhD focused on clinical applications in reconstructive surgery. Over time, he deepened his expertise in procedural dermatology, integrating academic knowledge with practical surgical skills. His academic achievements reflect a commitment to continual learning, allowing him to develop new techniques and contribute to the medical literature. This educational background positioned him as a leader in both the academic and clinical aspects of plastic and dermatologic surgery.

Experience

Dr. Bieniek’s professional experience is defined by a blend of clinical excellence, academic leadership, and private practice expertise . He has held significant roles in general and plastic surgery departments, where his skill and innovation have been recognized by peers and patients alike. Alongside his hospital work, he has developed a thriving private practice, offering aesthetic, dermatologic, and laser surgical services. His career includes extensive international training, where he collaborated with leading surgical centers across Europe and beyond. These experiences have enriched his practice with global perspectives and advanced procedural techniques. He also dedicates significant time to teaching medical students and leading postgraduate courses, ensuring that the next generation of surgeons inherits the highest standards of clinical care and innovation.

Research Interest

Dr. Bieniek’s research interests span several areas of surgical dermatology and reconstructive techniques . He is particularly focused on the surgical management of skin diseases, including skin cancers and hidradenitis suppurativa, where he develops methods that enhance both functional recovery and aesthetic results. His work also explores innovative procedural techniques that improve healing times and reduce complications, ensuring that patients benefit from safer and more effective interventions. Beyond clinical application, his studies contribute to the broader understanding of biomaterials and surgical methodology in dermatologic care. This research focus positions him as a thought leader in the field, with publications that influence surgical protocols worldwide and support evidence-based advancements in reconstructive and aesthetic surgery.

Awards

Dr. Bieniek has been honored multiple times for his exceptional work in medicine and education. These awards highlight his contributions to patient care, surgical research, and academic leadership. Colleagues and institutions have recognized his innovative approaches in dermatologic and plastic surgery, as well as his commitment to teaching and mentoring. These achievements not only celebrate his technical expertise but also his ability to inspire collaboration and foster innovation in medical practice. Each recognition underscores his dedication to advancing surgical standards and improving outcomes for patients. His reputation as a leader in his field reflects the trust and respect he has earned within the global medical community and among those he has trained and mentored throughout his career.

Publication Top Notes

Adipose derived stem cells – Sources, differentiation capacity and a new target for reconstructive and regenerative medicine

Journal: Biomedicine & Pharmacotherapy

Authors: Małgorzata Suchanecka; Joanna Grzelak; Maryam Farzaneh; Shirin Azizidoost; Mahrokh Abouali Gale Dari; Małgorzata Józkowiak; Krzysztof Data; Dominika Domagała; Julia Niebora; Katarzyna Kotrych; Bogusław Czerny; Adam Kamiński; Andrzej Bieniek; Jacek Szepietowski; Hanna Piotrowska-Kempisty; Piotr Dzięgiel; Paul Mozdziak; Bartosz Kempisty

Floating Island Flap”—A New Technique for the Reconstruction of Full-Thickness Lower Eyelid Defects with Spontaneous Healing (Folded V-Y Island Flap with Orbicularis Oculi Muscle)

Journal: Journal of Clinical Medicine

Authors: Andrzej Bieniek; Iwona Chlebicka; Katarzyna Kliniec; Jacek C. Szepietowski .

Polish guidelines for the diagnosis and treatment of hidradenitis suppurativa

Journal: Przegląd Dermatologiczny (Dermatology Review)

Authors: Łukasz Matusiak; Irena Walecka; Adam Reich; Andrzej Bieniek; Dorota Krasowska; Wioletta Barańska-Rybak; Beata Bergler-Czop; Aleksandra Lesiak; Joanna Narbutt; Agnieszka Owczarczyk-Saczonek; Witold Owczarek; Jacek Szepietowski.

Basal cell carcinoma and rosacea: coincidence or relationship?

Journal: Advances in Dermatology and Allergology (Postępy Dermatologii i Alergologii)

Authors: Iwona Chlebicka; Aleksandra A. Stefaniak; Andrzej Bieniek; et al.

Use of Dermatoscopy in Lesions Suspicious for Melanoma: Two Case Reports

Journal: Acta Dermato-Venereologica

Authors: Kevin Janczura; Iwona Chlebicka; Aleksandra A. Stefaniak; Andrzej Bieniek; Jacek C. Szepietowski

Conclusion

Dr. Andrzej Bieniek exemplifies a unique combination of surgical expertise, academic leadership, and research innovation . His dedication to patient-centered care and the advancement of dermatologic and reconstructive surgery has had a lasting impact on the field. By fostering collaboration between academic research and clinical practice, he has created pathways for continual improvement in surgical techniques and patient outcomes. His commitment to education ensures that his knowledge and experience are passed on to future generations of medical professionals, strengthening the foundation of surgical excellence. Through his work, Dr. Bieniek continues to inspire trust and respect, positioning himself as a leading voice in the evolution of modern dermatologic and plastic surgery.